Abattis Bioceuticals Corp. (CSE: ATT) appears to have avoided delisting from the Canadian Securities Exchange, if only narrowly. The equity was to be delisted at the close of market this evening as per the CSE bulletin. Abattis appears to have avoided the delisting event thanks to finally filing its audited financial statements late last night. … Continue reading Abattis Bioceuticals Narrowly Avoids Delisting from Canadian Securities Exchange